Could Omitting Radiotherapy After Breast-Conserving Surgery Be an Option for Older Patients With Early-Stage Breast Cancer?

According to a study, although locoregional recurrence risk increases somewhat when older early-stage breast cancer patients do not receive radiotherapy after breast-conserving surgery, overall survival does not differ.
Breast cancer, the most common cancer in women, develops when breast tissue cells grow and multiply uncontrollably for genetic or environmental reasons. Surgery is its primary treatment: tumor tissue formed by these abnormal cells is removed, followed by radiotherapy to prevent recurrence. For many years, surgery involved mastectomy, removing the entire affected breast. However, its significant cosmetic effects substantially reduce quality of life. Breast-conserving surgery (lumpectomy), removing only the tumor with a small amount of surrounding healthy tissue instead of the whole breast, has therefore become prominent in recent years. For this method, preferred for better appearance, minimizing locoregional recurrence is crucial. Radiotherapy is therefore always administered afterward.
Clinical trial results have made radiotherapy after breast-conserving surgery the fundamental approach in early-stage breast cancer. However, the patient profile in these studies matters: the vast majority are young patients, with older patients representing only %1-2. Assessing older patients through younger patients' data is inappropriate because mortality is higher and life expectancy shorter in older people. Radiotherapy may therefore affect them more psychologically and physically, and their treatment tolerance is lower. A recently published study compiled and analyzed studies consisting mostly of older early-stage breast cancer patients to examine whether radiotherapy is necessary after breast-conserving surgery.
The study compiled and analyzed data from 5 separate studies involving 3190 patients. Comparing those receiving and not receiving radiotherapy after breast-conserving surgery, the 5-year locoregional recurrence risk was % 2,2 with radiotherapy and % 6,5 without it. However, overall survival did not differ significantly between groups.
In conclusion, according to this study, older early-stage breast cancer patients who do not receive radiotherapy after breast-conserving surgery have a somewhat increased locoregional recurrence risk but no difference in overall survival. Considering recurrence risk, one could argue that radiotherapy is necessary; considering unchanged survival and patient age, one could also argue it is not essential. The best approach is for physician and patient to decide together, considering the patient's priorities and possible recurrence risk and its effects.
Sources
Was this article helpful?
Your feedback helps us improve our content.





Reader comments
Share your comment
Your name and comment are published only after administrator approval. Your email address is never shown to visitors.
Be the first to comment.